Most importantly, this approach identified multiple surface molecules whose role in myeloid leukemia remains unknown; these included integrin β7, siglec-F (CD170), CD72, LPAM-1 (integrin α4β7) and syndecan-1 (Sdc1, CD138) (Fig. 3a–c). The gene discussed is SDC1; the disease is myeloid leukemia.